公司資料
Cardiff Oncology 股價、新聞與催化劑
- 股票代碼:
- CRDF
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
0.90 USD (-6.10%)
收盤價
最後更新: 2026年8月17日
103M USD
市值
股價為何變動
As of Aug 17, 2026, CRDF closed down 6.10% at $0.9043. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Cardiff Oncology is an oncology company focused on precision cancer therapy and cell-cycle biology. Its development strategy is centered on targeted treatment combinations for solid tumors.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Cardiff sits in specialty oncology biotechnology.
商業模式特徵
The business depends on clinical data, pathway validation, and the ability to create a differentiated oncology franchise.
生技產業定位
Cardiff is a small-cap oncology catalyst name whose stock moves on early clinical readouts.
未來催化劑
- Cardiff Oncology’s catalysts are onvansertib and the KRAS-driven oncology program, especially any new combination or clinical data that keep the story alive. The company remains highly dependent on proof of differentiation.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。